Personalized Medicine Gets Boost From Court Ruling on PatentsBy and
Application of ’laws of nature’ are eligible for patents
Decision is boon to companies that feared stricter rules
The business of diagnostic treatments and personalized medicine got a boost Tuesday after an appeals court made it harder to invalidate certain patents by claiming they simply cover laws of nature.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.